Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

299

HTML

2464

Figures (1-2)

187

Tables (1-5)

197

Sum=3147

Publishing Process of This Article

Item

Count

Browse

823

Download

749

Sum=1572

Mar 14, 2013 (publication date) through Jul 23, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Mar 14, 2013; 19(10): 1618-1624
Published online Mar 14, 2013. doi: 10.3748/wjg.v19.i10.1618

Table 2 Clinical characteristics of Child A and B patients

PBC: Primary biliary cirrhosis; NBNC: Negative for both hepatitis C virus (HCV) and hepatitis B virus (HBV).

Citation: Kobayashi M, Kinekawa F, Matsuda K, Fujihara S, Nishiyama N, Nomura T, Tani J, Miyoshi H, Kobara H, Deguchi A, Yoneyama H, Mori H, Masaki T. Influence of percutaneous local therapy for hepatocellular carcinoma on gastric function. World J Gastroenterol 2013; 19(10): 1618-1624
URL: https://www.wjgnet.com/1007-9327/full/v19/i10/1618.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i10.1618